title: The physicochemical properties, plasma enzymatic hydrolysis, and nasal absorption of acyclovir and its 2'-ester prodrugs.
abstract: A series of 2'-(O-acyl) derivatives of 9-(2-hydroxyethoxymethyl)guanine (acyclovir) was synthesized by acid anhydride esterification. Aqueous solubilities in isotonic phosphate buffer (pH 7.4), partition coefficients in 1-octanol/phosphate buffer, and hydrolysis kinetics in rat plasma were determined. The ester prodrugs showed consistent increases in lipophilicity with corresponding decreases in aqueous solubility as a function of side-chain length. The bioconversion kinetics of the prodrugs appear to depend on both the apolar and the steric nature of the acyl substituents. When perfused through the rat nasal cavity using the in situ perfusion technique, acyclovir showed no measurable loss from the perfusate. Nasal uptake of acyclovir prodrugs, on the other hand, were moderately improved. Furthermore, the extent of nasal absorption appears to depend on the lipophilicity of the prodrugs in the descending order hexanoate > valerate > pivalate > butyrate. Simultaneous prodrug cleavage by nasal carboxylesterase was also noted in the case of hexanoate.
authors.affiliation: Department of Industrial and Physical Pharmacy, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana 47907-1336.
authors.forename: Z
authors.initials: Z
authors.lastname: Shao
authors.forename: G B
authors.initials: GB
authors.lastname: Park
authors.forename: R
authors.initials: R
authors.lastname: Krishnamoorthy
authors.forename: A K
authors.initials: AK
authors.lastname: Mitra
mesh_terms: D000042:Absorption; D000212:Acyclovir / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics*; D000281:Administration, Intranasal; D000818:Animals; D002021:Buffers; D043182:Carboxylesterase; D002265:Carboxylic Ester Hydrolases / Q000378:metabolism; D004951:Esterification; D004952:Esters; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D008297:Male; D009297:Nasal Mucosa / Q000378:metabolism*; D011355:Prodrugs / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012995:Solubility
chemical_list: D002021:Buffers; D004952:Esters; D011355:Prodrugs; D002265:Carboxylic Ester Hydrolases; D043182:Carboxylesterase; D000212:Acyclovir